Audiological Devices Industry to Experience $7 Billion in Revenue Growth by 2030: Detailed Analysis of the Global Market, Featuring Profiles of 169 Companies Operating in the Industry
Growth in Pediatric Hearing Care Market Catalyzes Development of Specialized Devices
Audiological Devices Market
Dublin, March 14, 2025 (GLOBE NEWSWIRE) -- The "Audiological Devices - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Audiological Devices was valued at US$14.7 Billion in 2024 and is projected to reach US$21.6 Billion by 2030, growing at a CAGR of 6.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the audiological devices market is driven by several factors. Technological advancements, such as the miniaturization of components and the integration of artificial intelligence, have significantly improved the functionality and convenience of hearing devices. The increasing incidence of hearing loss due to aging, noise pollution, and chronic diseases like diabetes has expanded the need for these devices. Moreover, greater awareness and destigmatization of hearing loss have encouraged more individuals to seek treatment.
The adoption of telehealth services has also facilitated easier access to audiological care, allowing for remote consultations and adjustments. Additionally, favorable reimbursement policies and government initiatives aimed at improving hearing health have supported market growth. As these trends continue, the audiological devices market is expected to expand, offering innovative solutions to meet the diverse needs of individuals with hearing impairments.Report ScopeThe report analyzes the Audiological Devices market, presented in terms of market value (USD). The analysis covers the key segments and geographic regions outlined below.SegmentsProduct Type (Hearing Aids, Cochlear Implants, BAHA / BAHS, Diagnostic Devices); Technology (Digital, Analog).Geographic Regions/CountriesWorld; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.Key Insights:
Market Growth: Understand the significant growth trajectory of the Hearing Aids segment, which is expected to reach US$14.3 Billion by 2030 with a CAGR of a 6.7%. The Cochlear Implants segment is also set to grow at 7.5% CAGR over the analysis period.
Regional Analysis: Gain insights into the U.S. market, valued at $3.8 Billion in 2024, and China, forecasted to grow at an impressive 10.1% CAGR to reach $5.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of players such as Advanced Bionics Corporation, AUDITDATA A/S, Bernafon AG, Cochlear Limited, GN ReSound A/S and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Questions Answered:
How is the Global Audiological Devices Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?
Some of the 169 companies featured in this Audiological Devices market report include:
Advanced Bionics Corporation
AUDITDATA A/S
Bernafon AG
Cochlear Limited
GN ReSound A/S
Natus Medical Inc.
Oticon A/S
Oticon Medical AB
Phonak AG
Sivantos Pte. Ltd.
Sonic Innovations Inc.
Sonova Holding AG
Starkey Hearing Technologies
Widex A/S
William Demant Holding A/S
Key Attributes
Report Attribute
Details
No. of Pages
337
Forecast Period
2024-2030
Estimated Market Value (USD) in 2024
$14.7 Billion
Forecasted Market Value (USD) by 2030
$21.6 Billion
Compound Annual Growth Rate
6.7%
Regions Covered
Global
MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Audiological Devices - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
MARKET TRENDS & DRIVERS
Growing Global Incidence of Hearing Loss Drives Demand for Audiological Devices
Technological Innovations in Hearing Aids and Cochlear Implants Enhance User Experience
Expansion of Telehealth and Remote Audiology Services Accelerates Market Growth
Aging Population Worldwide Bolsters Need for Hearing Solutions
Consumer Preference for Discreet and Advanced Hearing Aids Influences Product Design
Integration of Wireless Technology and Bluetooth in Audiological Devices
Emergence of AI and Machine Learning in Diagnostic and Therapeutic Audiological Solutions
Growth in Pediatric Hearing Care Market Catalyzes Development of Specialized Devices
Rise in Noise Pollution and Occupational Hearing Loss Challenges Market Dynamics
Advances in Battery Technology and Rechargeability Improve Device Longevity
Increased Focus on Customizable and Programmable Hearing Devices
For more information about this report visit https://www.researchandmarkets.com/r/qeagq0
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Audiological Devices Market
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Implantable Remote Patient Monitoring Devices Market to Grow 21.7% CAGR by 2029
"Innovation-Driven and Knowledge-Intensive: Implantable Remote Patient Monitoring Devices Seek Flexible, Integrated Solutions Amid Accelerating Market Timelines and Rising Competition" Boston, June 12, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the 'Global Implantable Remote Patient Monitoring Devices Market' is expected to grow from $7.6 billion in 2024 to $20.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% from 2024 to 2029. The report on the implantable remote patient monitoring (IRPM) device market analyzes market shares by product, indication and end users. It segments the market into device types, such as cardiovascular, brain, gastrointestinal, hematological, respiratory, and musculoskeletal monitoring devices. Indication consists of cardiovascular diseases, brain disorders, and diabetes End users include hospitals, clinics, and home healthcare settings. Additionally, it offers a study of the competitive landscape, regional analysis, consumer insights, and a supply chain analysis, helping stakeholders make informed decisions and identify strategic opportunities. This report is particularly relevant today because implantable remote patient monitoring (IRPM) devices are transforming healthcare by enhancing patient outcomes, lowering healthcare costs, and increasing accessibility. These devices facilitate continuous monitoring of chronic conditions, enabling real-time data collection and analysis, which can lead to early detection of complications and more timely interventions. The factors driving the market's growth include: Chronic Diseases and the Aging Population: The rise in chronic diseases and the global aging population increase the need for continuous health monitoring. Implantable devices help manage these conditions more effectively, reducing hospital visits and improving patient outcomes. Demand for mHealth Applications: mHealth apps are gaining in popularity for their convenience and real-time health data. They enhance implantable devices by providing comprehensive health data, driven by the widespread use of smartphones and rising awareness of the benefits of digital health. Improved Wireless Technologies: Advances in wireless tech, such as 5G, improve the reliability and efficiency of remote patient monitoring. These technologies enable faster data transmission and more stable connections, which are crucial for real-time health monitoring. Request a sample copy of the global market for implantable remote patient monitoring (IRPM) devices report. Report Synopsis Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $6.5 billion Market size forecast $20.3 billion Growth rate CAGR of 21.7% from 2024 to 2029 Segments covered By product, disease indication, end user, and region Regions covered North America, Europe, Asia-Pacific, and the Rest of World (RoW) Market drivers Increasing prevalence of chronic diseases due to an aging population. Growing demand for mHealth applications. Improved wireless communication technologies. Interesting facts: Reducing Hospital Readmissions: Implantable RPM devices can decrease hospital readmissions by up to 30%, which is crucial for managing chronic conditions like heart failure. Innovative Power Sources and AI Integration: Some implantable devices are powered by the human body, eliminating the need for external batteries. Additionally, integrating artificial intelligence (AI) enhances their predictive capabilities, allowing real-time adjustments to patient care. The report addresses the following questions: What is the projected size and growth rate of the global market for implantable remote patient monitoring devices? The global market for implantable remote patient monitoring devices was valued at $6.5 billion in 2023 and is expected to reach $20.3 billion by the end of 2029, at a CAGR of 21.7% from 2024 to 2029. What are the key factors driving the growth of the market? These include the increasing prevalence of chronic diseases due to an aging population, growing demand for mHealth applications, and improved wireless communication technologies. What market segments does the report cover? The global market for implantable remote patient monitoring devices is segmented by product, indication, end user and region. Which indication segment will enjoy market dominance through the forecast period? The cardiovascular diseases segment will have that position. Which region has the largest share of the global market for implantable remote patient monitoring devices? North America holds the largest share of the market. Leading Companies Include: ABBOTT AVERTIX MEDICAL INC. BIOTRONIK BOSTON SCIENTIFIC CORP. CARDIAC RMS DEXCOM INC. EBR SYSTEMS INC. ENDOTRONIX INC. INJECTSENSE INC. IMPULSE DYNAMICS MEDICO S.R.L. MEDTRONIC PROFUSA INC. QURA LLC. VITALCONNECT Navigate Uncertainty with ConfidenceIn times of rapid change and uncertainty, having the right insights can make all the difference. At BCC Research, we are here to support innovation and help you stay ahead. Our custom research reports provide a comprehensive, 360-degree view of your market landscape, giving you the clarity you need to make informed decisions. We believe that timely, expert market intelligence should be accessible to all. That is why, for a limited time, we are offering 30% off the price of any BCC Research report to help more organizations gain access to our latest data and insights. Purchase a copy of the report directly from BCC Research. For further information on any of these reports or to make a purchase, contact info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. CONTACT: BCC Research Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA Email: info@ Phone: +1 781-489-7301Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Hamilton Spectator
4 hours ago
- Hamilton Spectator
First of Its Kind in the Region: KFSHRC Successfully Performs Endoscopic Sleeve Gastroplasty on Kidney Transplant Patient
RIYADH, Saudi Arabia, June 12, 2025 (GLOBE NEWSWIRE) — In a medical achievement considered the first of its kind in the region, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has successfully performed an endoscopic sleeve gastroplasty (ESG) on a patient who had previously undergone a kidney transplant, a case that requires meticulous management of immunosuppressive medications and the prevention of any complications that could jeopardize the transplanted organ. This procedure marks a significant advancement in providing safe treatment solutions for transplant recipients, to improve their graft survival and quality of life. Known as Endoscopic Sleeve Gastroplasty (ESG), the procedure differs from surgical sleeve gastrectomy in that it requires no abdominal incisions, which is important for transplant patients. Instead, it uses an endoscope inserted through the mouth to suture the stomach internally, effectively reducing its volume and enabling the patient to lose weight and improve overall health. The procedure aimed to address obesity and metabolic, which are among the leading factors that can negatively impact the health of a transplanted kidney, increase cardiovascular risk, and reduce long-term patient outcomes. The procedure was performed by a multidisciplinary team of medical experts, led by Dr. Ehab Abufarhaneh, Consultant in Adult Transplant Gastroenterology and Hepatology. The team included gastroenterologists, an upper GI surgeon, transplant surgeons, transplant Nephrology, and transplant anaesthesiologists, all supported by highly trained nursing staff to ensure the highest level of safety, with particular focus on managing the patient's immunosuppressive regimen—critical to preserving kidney graft function. This achievement underscores the pivotal role of KFSHRC's Organ Transplant Centre of Excellence as a leading medical environment capable of delivering precise interventions for complex transplant cases. By adopting innovative techniques tailored to the unique needs of transplant patients and developing treatment protocols that address post-transplant challenges, the centre reinforces its position as a regional referral hub for cases beyond the scope of conventional treatment pathways. The success of this procedure further exemplifies KFSHRC's ongoing commitment to delivering advanced, patient-centred healthcare and fulfilling its vision of being the optimal choice for patients supported by an integrated ecosystem of education, research, and clinical excellence that aligns with the ambitions of Saudi Arabia's health sector. It is noteworthy that KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit or contact our media team at mediacoverage@ . A photo accompanying this announcement is available at
Business Insider
4 hours ago
- Business Insider
Trump says 'changes' are coming to immigration enforcement after complaints from farmers and the hospitality industry
There may be some changes coming to the Trump administration's approach to immigration enforcement. President Donald Trump said in a Truth Social post on Thursday that both farmers and "people in the Hotel and Leisure business" have said that his approach to immigration enforcement "is taking very good, long time workers away from them, with those jobs being almost impossible to replace." "In many cases the Criminals allowed into our Country by the VERY Stupid Biden Open Borders Policy are applying for those jobs," Trump added. "This is not good. We must protect our Farmers, but get the CRIMINALS OUT OF THE USA. Changes are coming!" At a White House event later on Thursday, he said that "we're going to have an order on that pretty soon, I think." "We can't do that to our farmers," Trump said. "We're going to have to use a lot of common sense." It comes one day after Tom Homan, the Executive Associate Director of Enforcement and Removal Operations, told Semafor that the administration would begin prosecuting companies that employ immigrants living in the country illegally. According to Census data, the agriculture and leisure industries have relatively high proportions of non-US citizen workers.
